Training Programs in Vascular Biology
NIH-Supported “T32” Research Training Fellowship in Resuscitation Science – Beth Israel Deaconess Medical Center
Michael Donnino, MD
Professor of Emergency Medicine, HMS
Director, Center for Resuscitation Science
T32 Fellowship Program Director
Samir Parikh, MD
Professor of Medicine, HMS
T32 Fellowship Co-director
Murray Mittleman, MD
Professor of Epidemiology, HSPH
T32 Fellowship Co-director
Michael Donnino, MD
Francesca Montillo, MM
Program Scope and Mission – This is an outstanding training OPPORTUNITY to jump-start an academic career in RESUSCITATION SCIENCE. Funded by an NIH T32 training grant, the Resuscitation Science Fellowship is the only such program focused exclusively on resuscitation nationally. The Resuscitation Science Fellowship is based primarily at Beth Israel Deaconess Medical Center (BIDMC) with collaborations and mentors spanning Massachusetts General Hospital, Brigham and Women’s Hospital, Boston Children’s Hospital, MIT, and Boston University Medical Center. This program can be a key early step for junior investigators who wish to pursue academic research in this rapidly growing field.
What is Resuscitation Science? Resuscitation science is a sub-specialty of critical care/emergency medicine focused on understanding the etiology, pathophysiology, and treatment of critical illnesses including sepsis, ARDS, and cardiac arrest.
Program Mission: The overall goal of the program is to train well-rounded junior investigators who intend to continue in academic medicine in the field of resuscitation science.
Program Faculty: Led collaboratively by Drs. Michael Donnino, Murray Mittleman, and Samir Parikh, the 20 program faculty mentors are nationally and/or internationally recognized research leaders whose prolific research laboratories have accounted hundreds of high impact publications, many authored by mentees. They are equally accomplished in training junior investigators, having won numerous teaching awards and serving as primary or secondary research mentors for >80 NIH and foundation mentee-driven training awards.
• Flexibility in training approaches! There are separate tracks for those interested in clinical trials, epidemiology/data science, or laboratory research, but you will gain a good understanding of all 3 approaches.
• Fellows can focus their training on either adult or pediatric resuscitation research
• Didactic component provides a broad background spanning the breadth of resuscitation approaches and disciplines. Didactics includes some core coursework, some optional coursework, as well as research seminars, laboratory meetings, and national conference participation.
• Hands-on research training includes clinical trials and epidemiologic/big data studies for cardiac arrest, sepsis, ARDS, and other areas, as well as pertinent laboratory science investigations using animal models and cutting edge laboratory techniques. Collaborations with fellows and investigators in other track are encouraged.
• Fellows will devote a minimum of 35 hours per week over 2-3 years. 100% protected time for MD fellows. All fellows are expected to apply for an NIH K mentored grant (or foundational equivalent) at the end of their training.
• Fellows will enter at the PGY 1 – PGY 6 salary level depending on their experience and past training.
Eligibility and Program Admission Criteria. Eligible MD candidates include physicians specializing in emergency medicine and/or critical care-related disciplines (adult or pediatric) who have completed at least 3 years of residency. Eligible PhD candidates are postdocs interested in epidemiology and translational research pertinent to resuscitation. In either case, the ideal candidate would be seeking NIH funding following completion of this fellowship with the intent of pursuing an academic research career in resuscitation science. Candidates will be evaluated based on past research experience/performance, academic record, and a subjective evaluation of their potential for leadership in resuscitation research. Candidates must be a US citizen or a legal permanent resident of the US. .
Harvard-Longwood Research Training in Vascular Surgery – Beth Israel Deaconess Medical Center
Frank W. LoGerfo, M.D.
William McDermott Distinguished Professor of Surgery
Leena Pradhan-Nabzdyk, Ph.D., M.B.A.
Instructor in Surgery
Harvard Medical School
Beth Israel Deaconess Medical Center
Vascular Surgery Research-East Campus
330 Brookline Ave. Dana 805
Boston, MA 02215
Program Scope and Mission – The Harvard-Longwood Research Training in Vascular Surgery Program is designed to provide two years of intense basic research training in cardiovascular surgery for academic clinicians. The training program addresses the absence of adequate research training for cardiovascular surgeons as it applies to specific areas of clinical disease. This program is fully funded by the National Institutes of Health.Research training in molecular and cell biology, biomechanics, coagulation and thrombosis, and angiogenesis is provided with a focus on clinically relevant problems such as artherogenesis, intimal hyperplasia, prosthetic/host interactions and thrombosis. Trainees pursue a program of intense research design, ethics, statistics, and evaluation of published research. Trainees carry out their own research projects under the guidance of a faculty mentor. (They are not involved in any clinical activities unless research related.) Laboratory training can be supplemented by graduate level training at Harvard Medical School and Harvard’s Faculty of Arts and Sciences, with course selection complementing laboratory endeavors. Upon completion of the program, trainees are capable of independent research and possess the scientific and research background needed to obtain competitive grants; they have the abilities and knowledge necessary to provide translational expertise as they join medical school faculties.
Nephrology Fellowship – Beth Israel Deaconess Medical Center
Dr. Martin Pollack, M.D.
Professor of Medicine
Nephrology Fellowship Program
Catherine Nadir, Fellowship Administrator
Libby Building – West Campus
171 Pilgrim Road – Libby 2
Boston, MA 02215
Program Scope and Mission – The Beth Israel Deaconess Medical Center (BIDMC) Division of Nephrology is dedicated to providing the highest-quality care to patients, advancing nephrology research and training future physicians and investigators to become leaders in the field. Decades before Boston's Beth Israel and New England Deaconess hospitals came together as Beth Israel Deaconess Medical Center; each was a leader in health care with a long history of personalized patient care and community service. In 1996, the two hospitals merged to form BIDMC. Today, with nearly three quarters of a million patient visits each year in and around Boston, BIDMC is rated among the top hospitals in the country in patient care and National Institutes of Health funding. Like BIDMC, the Division of Nephrology has a rich and remarkable history, boasting an impressive lineage of members and leaders.Our educational programs are among our program's greatest strengths. Our faculty is recognized locally, nationally and internationally for their excellence in medical education. They serve as core educators in our fellowship program, BIDMC's Internal Medicine Residency Program and at Harvard Medical School. Our educational mission is to train the future leaders of nephrology. The nephrology training program at BIDMC offers a dynamic mix of clinical care as well as basic and translational research, using novel educational approaches in a warm and nurturing environment. Whether our trainees provide superlative care, perform clinical or laboratory research or take on educational roles, our fellowship program provides the tools necessary to chart the future of our specialty.
Cardiovascular Medicine Fellowship – Beth Israel Deaconess Medical Center
Dr. Murray A. Mittleman, Dr.P.H., M.D., D.Ec.
Professor of Epidemiology
Associate Professor of Medicine
Program Scope and Mission – The past two decades have brought miraculous advances in the field of cardiovascular medicine. At Beth Israel Deaconess Medical Center — a major teaching hospital of Harvard Medical School — our physician-scientists have been deeply engaged in making progress and saving lives.We offer our fellows the opportunity to play a role in breakthroughs across the spectrum of research and clinical care: predictive medicine, molecular biology, translational research, new technologies, novel therapies, innovative care delivery systems and outcomes research. We invite you to explore whether our program is right for you. Welcome.
The Multidisciplinary Training Grant (T32) in Cardiovascular Epidemiology - Boston University
Vasan Ramachandran, MD
Section of Preventive Medicine & Epidemiology| Department of Medicine
801 Mass Ave, 4th floor | Boston, MA 02118
Office: (617) 638-8009
Program Scope and Mission – The Multidisciplinary Training Grant (T32) in Cardiovascular Epidemiology is a training awarded by the National Heart, Lung, and Blood Institute. Trainees will focus their 2-year training on the epidemiology of cardiovascular disease such as coronary heart disease, stroke, heart failure and other forms of vascular disease, following one of the training pathways: statistical genetics and genomics, computational biology and bioinformatics, or clinical epidemiology.This position is a postdoctoral training opportunity paid a stipend, and the successful individual will be engaged in a temporary and a defined period (2-year) of mentored advanced training and professional development following completion of a doctoral degree program.
Training in Blood Diseases and Resources, T32 HL007501 - Boston University
Co-Directors Hematology Training Program:
Kevan Hartshorn - Director, Fellowship Program in Hematology/Oncology
Martin H Steinberg
Professor of Medicine, Pediatrics, Pathology and Laboratory Medicine
Boston University School of Medicine
72 E. Concord St.
Boston, MA 02118
Program Scope and Mission – The Boston University-Boston Medical Center Training Program in Blood Diseases and Resources” is a training program in hematology research that has been active at Boston Medical Center since 1980, currently supporting four pre-doctoral and four post-doctoral trainees/year. The objective of this training program is to provide training in hematology research to graduate students and PhD, MD, or MD, PhD post-doctoral trainees who work with any of 21 faculty. Our program faculty carry out hematology-related research in four areas: Hemoglobinopathies, Platelet and Thrombosis Biology, Hematopoiesis, and Lymphoid Cell Signaling and Immunopathology. We offer a rich research environment for trainees interested in hematology-related basic science, translational or clinical research projects. Among the research resources in hematoloic diseases available to trainees are the Boston University Center of Excellence in Sickle Cell Disease, the Center for Regenerative Medicine and the Amyloidosis Center. One of the strengths of the program is regular interaction at weekly Journal Clubs and Work Seminars between supported doctoral students, post-doctoral fellows and physicians carrying out their hematology fellowships. At the weekly Hematology Grand Rounds, talks are given by outside hematology researchers and such experts are made available to meet with trainees. Doctoral students enter the after having matriculated in variety of doctoral programs, including Biochemistry, Biology, Biostatistics, Microbiology, Molecular Medicine, Pathology and Pharmacology. A clinical research track is now offered to physicians who wish to obtain training in hematology-related clinical research.
NRSA Institutional Pre-doctoral Training Grant Training in Biomolecular Pharmacology - Boston University School of Medicine
David H. Farb
Richard Wainford, PhD, FAHA
Department of Pharmacology, Boston University
Program Scope and Mission – Of the 61 appointees to the Biomolecular Pharmacology Training Grant in the last 15 years, 87% earned the Ph.D. degree. The average time-to-degree has been 5.2 years for the 20 most recent graduates enrolled since September 2007. The current professional positions of graduates in the last 15 years reflect the diversity of opportunities available for Ph.D.s with expertise in pharmacology.There are three points of entry into the Biomolecular Pharmacology training program: PhD in Pharmacology, PhD in Biomedical Engineering, and PhD in Neuroscience. For more information visit the website. https://www.bumc.bu.edu/busm-pm/programs/
Training Program in Cardiovascular Biology, Pre-doctoral – Boston University School of Medicine
Katya Ravid, D.Sc.
Professor of Medicine and Biochemistry
700 Albany St Ctr for Adv Biomed Res
Phone: (617) 638-5053
Executive Assistant: Robin MacDonald
BU Interdisciplinary Biomedical Research Office
Program Scope and Mission – Cardiovascular diseases represent the major causes of mortality and morbidity in the United States, and thus calls for major efforts in fundamental research. The training program, supported by the National Heart Lung and Blood Institute (NHLBI), provides a format for the training of future scientists who will devote time and efforts in developing the tools to study and control the disease.This program was initiated by Dr. Katya Ravid in 2003, inspired by Drs. Peter Brecher and the late Carl Apstein, prominent investigators and mentors in the field of Cardiovascular Biology. Training is offered to graduate students in topics related to cardiovascular disease, including atherosclerosis heart failure and hypertension, with application of disciplines such as, physiology, pharmacology, biochemistry, molecular biology and genetics. Trainees participate in various activities of the Whitaker Cardiovascular Institute (CVI) at our institute. The training faculty is affiliated with basic science departments and with the CVI. Each faculty has experience in teaching graduate courses, most have had numerous trainees that have gone on to hold academic positions, and all have at least one active grant from NIH. The program may be unique in that it provides an opportunity to train pre-doctoral fellows (PhD students and MD/PhD students) in translational and basic cardiovascular research in an academic setting in which considerable experience is available, where cutting-edge funded research in cardiovascular biology is ongoing, and where sensitivity to the need of graduate students is provided by an academic mentor approach.
Whitaker Cardiovascular Institute Training Program – Boston University School of Medicine
Victoria Bolotina, Ph.D.
Professor of Medicine, Physiology, and Biophysics
Whitaker Cardiovascular Institute
Program Scope and Mission – This program is unique, as it offers multidisciplinary state-of-the-art resources, advanced expertise of leading experts in the field, and professional guidance to a highly qualified and motivated group of post-doctoral fellows who want to pursue successful carriers in cardiovascular science. The program has developed a highly interactive research and training environment with successful collaborative initiatives which represent major fields of cardiovascular biology. Our mentors are the leading experts in the following fields:• Vascular Biology
• Diabetes and Obesity
• Basic Science
• Clinical Science (Translational Research)
• Regenerative Medicine
The Renal Section Training Program – Boston University School of Medicine
David J. Salant, M.D.
Chief, Section of Nephrology
Professor of Pathology and Laboratory Medicine
Dr. Craig Gordon
Director of Training Program in Nephrology
Boston Medical Center, Renal Section
650 Albany Street 5th Floor, Rm 504
Boston, MA 02118-2393
Phone: (617) 638-7330
Program Scope and Mission – The Renal Section offers comprehensive clinical and research training. The training programs are supervised by a large full-time staff, which currently includes 21 nephrologists and medical scientists, as well as several associate research training faculties. The size of the staff allows for broad coverage of the various clinical and research areas of nephrology. It also provides intensive supervision of fellows during both clinical and research training. Most fellows are physicians who have completed their training as the basis for a career in academic nephrology. For these individuals, a comprehensive fellowship program includes one year of clinical training in nephrology, usually but not necessarily taken first, and two or more years of research training. Other physician-trainees, anticipating a career in clinical nephrology, take the year of training in clinical nephrology followed by a year or more of training in clinical investigation.Training positions are also open to medical scientists with a Ph.D. degree who wish to receive post-doctoral fellowship training in aspects of physiology, molecular and cell biology, immunology and clinical research related to the kidney or its diseases. In addition, close ties have been established with basic scientists in other departments and sections of the Department of Medicine, which affords fellows the opportunity of training in molecular biology and basic immunology.
Endocrinology, Diabetes & Hypertension - Brigham & Women’s Hospital
Gordon H. Williams, MD
221 Longwood Avenue
Boston, MA 02115
Fellowship Program Coordinator
Ole-Petter R. Hamnvik, M.B. B.Ch., B.A.O., M.M.Sc.
Fellowship Program Coordinator
Program Scope and Mission – A vibrant post doctoral Training Program in cardiovascular endocrinology and the cardiovascular and renal aspects of hypertension and diabetes mellitus has existed at Brigham and Women’s Hospital (BWH) (and its predecessor, Peter Bent Brigham Hospital) for over 50 years with an expansion a decade ago to include Morehouse School of Medicine. The Training Program’s continued success has been built on four premises: 1) dedicated trainers committed to the concept of long term effective mentoring; 2) creative mentees dedicated to establishing a lifelong career as biomedical scientists; 3) a pool of junior scientists committed to developing careers as mentors; 4) a dynamic and flexible group of knowledgeable scientists, external to the Core faculty and willing to serve as co-mentors, with expertise in disciplines critical for the career development of mentees. The expertise represented by our faculty members is far-reaching and diverse, including: pathophysiology of hypertension and of vascular diseases in diabetes mellitus, non-renal aspects of aldosterone action, pregnancy-induced hypertension, interventional nutrition, ion transport mechanisms, human genetics, regulation of gene expression, functional genomics, the molecular biology of the vasculature, the physiologic, molecular and cellular biology of veins and arteries, the effect of ethnicity and sex on vascular function and hypertension, regulation and function of natriuretic hormones, and regulation of the renal circulation and electrolyte handling. The disciplines represented are cardiology, endocrinology, nephrology, surgery, genetics, physiology, radiology, neurology, and cell and molecular biology. The techniques include human and intact animal cardiovascular function, ex vivo vascular function, immunology, development of genetically engineered mice, molecular and cell biology, quantitative assays for assessment of hormones and transduction and ionic factors. Finally, our program’s singular focus is the amalgamation of committed, established biomedical scientists with mature, highly motivated trainees to facilitate the mentees obtaining the tools and learning the concepts of biomedical science. Thus, the three-fold goal of this program is to provide a training experience that will allow the trainee to: create and perform independent research; obtain financial support for that research; and develop the tools necessary to be an effective mentor.
Brown Respiratory Research Training Program - Brown University
Elizabeth Harrington, Ph.D.
Professor of Medicine, Associate Dean for Graduate and Postdoctoral Studies
Program Scope and Mission – The Brown Respiratory Research Training Program (BRRTP) is a T32 grant with an overall objective the training of physicians and scientists who will become independent investigators in the pathobiology of respiratory diseases and in the health services, outcomes, and epidemiology of these diseases. This will be accomplished by a rigorous program of didactic and career development training and mentored research experience in a collaborative, multidisciplinary setting. The BRRTP aims to bridge gaps between biomedical, behavioral and public health disciplines to advance knowledge regarding how best to reduce disease burden among patients with diseases that affect the respiratory system. The program supports a total of 4 graduate students and 4 postdoctoral trainees per year.Nominations are being accepted through December 14, 2018 for grant support for one new graduate (PhD) student and two new postdoctoral trainees (MD, PhD, or MD/PhD) in the upcoming program year, which starts on February 1, 2019. Trainees will be supported for up to 2 years of research training. Full details and application information are available on our website.
Training in Molecular Therapeutics for Pediatric Cardiology - The Children's Hospital of Philadelphia
Robert J. Levy, MD
Joseph W. Rossano, MD
Email: kernss@ chop.edu
Program Scope and Mission – Forefront National Institutes of Health (NIH)-sponsored postdoctoral research training is offered in three specific areas: Cardiovascular Pharmacology and Gene Therapy; Cardiac Development; Cardiovascular Pathophysiology. A collaborative training program is offered involving participation of leading scientists at the Children’s Hospital of Philadelphia, and the Perelman School of Medicine at the University of Pennsylvania. Examples of ongoing research directions include: Tissue Engineering, Cardiac Development, Biomaterials, Nanoparticles, Gene Therapy for Vascular Injury, and for Cardiac Arrhythmias. Opportunity to participate in clinical research training for CHOP clinical Fellows via enrollment in the University of Pennsylvania Masters of Science in Clinical Epidemiology or other Masters degree programs is available. This program has successfully recruited under-represented minority scholars, and seeks to expand this dimension.
Training Program in Lung Science - Columbia University
Jahar Bhattacharya, MD, DPhil
Phone: (212) 305-7310
Fax: (212) 305-6701
Program Scope and Mission – The purpose of this T32 training program (Columbia University Training Program in Lung Science) is to provide an opportunity to promising post-doctoral individuals of exceptional quality to train in careers in pulmonary research. The program is limited to applicants who hold the MD, PhD or MD/PhD degrees and have a strong interest in research. The central features of the Program include intensive research with participating faculty members and didactic exposure to multiple courses in basic and translational science in pulmonology. Research areas span a wide range of pulmonary disciplines with centers of excellence in Acute Lung Injury (ALI), Lung Development, Asthma/COPD and Lung Vascular Biology. Expertise in biochemistry, cell biology, molecular biology, mouse genetics, biomechanics, and physiology are all well represented by the faculty. Highly experienced investigators provide expertise to fellows in a wide variety of subspecialties, including ALI, Infection and Asthma/COPD. Trainees are selected from a competitive pool of applicants. All trainees thus far have gone on to academic careers in pulmonology.
Postdoctoral Training in Arteriosclerosis Research – Columbia University Health Sciences Campus
Director and Contact:
Henry N. Ginsberg, M.D.
Irving Professor of Medicine
Founding Past Director
Irving Institute for Clinical and Translational Research
630 West 168th Street
New York, NY 10032
Phone: (212) 305-9562
Fax: (212) 305-3213
Program Scope and Mission – The Columbia University Health Sciences Campus provides research training in the broad area of cardiovascular disease and specifically in the area of arteriosclerosis. The program supports eight trainees per year. Trainees must be United States citizens or permanent residents. In addition, applicants/trainees must hold a doctoral degree. Usually, this degree will be an M.D. or Ph.D. but holders of other doctoral degrees are encouraged to applied. Trainees are required to undertake a minimum of two years of training, with three years being the norm.The training faculty of the program consists of approximately forty faculty from different units throughout the Medical Center. The research interests of this faculty are diverse and encompasses basic, clinical, observational, and applied research. Trainees will work directly with a member of our training faculty. Ideal candidates for obtaining a position in the training program will be those interested in pursuing research careers. We encourage members of underrepresented minority groups to apply to our program.
Irving Institute TL1 Training Program – Columbia University Medical Center
Wendy K. Chung, MD, PhD
Kennedy Family Professor of Pediatrics and Medicine
Sophia Li Ferry
Program Scope and Mission – The TRANSFORM TL1 Training Programs are intended to provide scholars with additional research training to prepare for a research career that can contribute in some meaningful way to understanding risk of disease, improving diagnosis and prevention, and tailoring treatment based on an individual’s variation in genes, environment, and/or lifestyle.With funding from the NIH CTSA award, the Irving Institute for Clinical and Translational Research seeks to promote high-quality research, enhance the integration of clinical and translational science, and deliver advancements more quickly to the patient community. An integral part of this effort is the TL1 Training Programs. We are recruiting applicants for the following programs:
• Post-Doctoral Fellows (2 year commitment to the program)
• Doctoral students (3 month commitment to the summer program) Eligibility (see website for more details):
• Must be a US Citizen or Permanent Resident
• Must have a Columbia appointment, position, or acceptance letter by the start of the award. We do not offer post-doc appointments nor do we accept students who are not formally enrolled in degree granting programs.
• Must have two interdisciplinary mentors. We can assist with connecting applicants to mentors, if needed. Here are some examples of potential research topics:
• Ecological momentary assessment of stress to identify personalized triggers for atrial fibrillation
• Using genetic profile of breast cancer tissue to target therapy
• N-of-1 trial to assess individualized treatment strategy for hypertension
• Apply machine learning to EHR data to predict individualized risk of hospital readmissions
• Integrating data from wearable devices with neighborhood walkability index to predict cardiovascular risk.
Translational Cardiovascular Research, Pre-doctoral Training – Columbia Medical Center
Andrew R. Marks, M.D.
Chairman, Department of Physiology
Founding Director, Center for Molecular Cardiology
Professor, Physiology & Cellular Biophysics; Medicine
Henry Colecraft Ph.D.
Program Scope and Mission – The graduate program in Cellular Physiology and Biophysics includes a training program in Translational Cardiovascular Research. This is an optional program for students interested in pursuing advanced graduate training in cardiovascular biomedical research. It is a unique NIH funded program that also supports post-doctoral fellows.The training program in Translational Cardiovascular Research is conceived to enhance and ensure the development of cardiovascular scientists who have broad-based knowledge in the fields of Cardiovascular Cell Biology, Biophysics, Genetics and Genomics, Bio- and Tissue-Engineering and Clinical Sciences. The training is based within the Clyde and Helen Wu Center for Molecular Cardiology, the Department of Physiology & Cellular Biophysics, and the Department of Medicine. The Center and the Departments of Physiology and Medicine offer a Cardiovascular Seminar Series and journal clubs, joint laboratory meetings, and retreats, which are designed to encourage collaborations and foster excellence. This component of the Department’s Graduate Program seeks to prepare tomorrow’s cardiovascular scientists and endow them with clinical/pathophysiological insights, developing a group of investigators that is focused upon clinically relevant investigation in matters pertinent to heart and vascular diseases. Applicants may have co-mentors, one with primarily basic science expertise and one with translational/clinical science expertise.
Cardiovascular Endocrine Research Fellowship – Harvard Medical School/Brigham and Women’s Hospital
Director and Contact:
Gail K. Adler, MD, PhD, FAHA
Program Scope and Mission – A 2 to 3-year Cardiovascular Endocrine Research Fellowship is available at Brigham and Women’s Hospital, Harvard Medical School, and is designed to prepare bench scientists and clinical/translational scientists for successful research careers in Endocrinology, Genetics, Cardiology, and/or Nephrology. The program investigates genetic and hormonal mechanisms associated with cardiovascular and renal disease in hypertension, obesity and diabetes. Basic scientists receive training in cell, organ and animal physiology, and molecular biology. Clinical scientists receive training in human physiology, pathophysiology, genetics and clinical trials. Genes currently under investigation include: caveolin 1, angiotensinogen, LSD1, striatin, mTORC, ERAP1, beta 2 adrenergic receptor and estrogen receptor beta. Areas of interest include aldosterone and mineralocorticoid receptor mediated cardiorenal and vascular damage, and cardiometabolic diseases associated with complications of pregnancy. A common goal of our translational research group is to understand pathophysiological mechanisms and to develop specific approaches to personalized medicine. Candidates should have a PhD and/or MD and must be a US citizen or permanent resident. This well-established program has been supported by an NIH T32 Training Grant for more than 40 years; salaries are based on the current NIH stipend levels. More than 80% of the graduates have research careers in academia, government or industry.
Research methods in pediatric cardiology – Harvard Medical School
William Pu, MD
Professor of Pediatrics
Director of Basic and Translational Research
Department of Cardiology
Boston Children’s Hospital
300 Longwood Ave
Boston, MA 02115
William Pu, MD
Professor of Pediatrics
Boston Children’s Hospital
300 Longwood Ave.
Boston, MA 02115
Program Scope and Mission – This T32 program is for postdoctoral (MD, PhD, or MD PhD) trainees interested in cardiovascular biology or pediatric cardiology. Based in the Department of Cardiology at Boston Children’s Hospital and Harvard Medical School, the training program spans the breadth of basic, translational, and clinical research in vascular biology and cardiac biology. Among the program’s faculty mentors are leaders in these fields, including: William Pu; Jane Newburger, Jon and Christine Seidman; Rob Gerszten; Anthony Rosenzweig, Calum MacRae, Timothy Hla, Joyce Bischoff, Geoff and Caroline Burns, Da-Zhi Wang, Kaifu Chen, and Sarah de Ferranti.The program is committed to developing the next generation of researchers in cardiovascular biology. It is committed to a diverse biomedical workforce, including groups traditionally under-represented in biomedical research.
Pre-doctoral and Post-doctoral Training Program in Cardiovascular Epidemiology – Harvard T.H. Chan School of Public Health
Dr. Eric Rimm or
Dr. Goodarz Danaei
Program Scope and Mission – The Department of Epidemiology at the Harvard T.H. Chan School of Public Health is pleased to offer an NHLBI-funded T32 pre-doctoral and post-doctoral training slot in our Program in Cardiovascular Epidemiology. This training grant is funding a research and training position to study the effects of behavior, the environment, and global health on CVD. This Program is training both pre- and post-doctoral trainees in the rich academic environment of the Harvard T.H. Chan School of Public Health and affiliated institutions locally and worldwide, bringing together outstanding faculty mentors to provide integrated and interdisciplinary experiences and collaborative interactions, specialized curriculum with core and elective coursework, nondidactic practical career training, individual candidate training plans, and opportunities for translation and policy evaluation.Under the guidance of the Mentor and co-Mentor and according to the interests of each trainee, training is directed toward investigating effects of both established and novel behavioral and environmental risk factors, their personal and population determinants, and the effective interventions to change them, integrating influences of individual susceptibility and psychosocial, educational, neighborhood, and environmental conditions in both developed and developing nations. Training includes modern methodological and analytical techniques required to study the intersections of Behavior with cardiometabolic diseases, including observational epidemiology and interventions in adulthood, adolescence, and early life; the Environment, including nutrition, airborne and environmental toxins, social risks, and physical (built) environment; and Global Health, including observational epidemiology, demography, comparative risk assessment, and controlled interventions at both individual and community levels.
Cardiology Fellowship Program – Icahn School of Medicine at Mount Sinai
Bruce D. Gelb, M.D.
Director Mindich Child Health and Development Institute
Professor of Pediatrics, Cardiology, and Genetics and Genomic Sciences
Program Scope and Mission – Recognizing that the future of basic cardiovascular research is in molecular approaches, Mount Sinai has made a major commitment towards developing one of the premier programs in the country. Established scientists in specific programs and centers perform cutting edge research illuminating cardiovascular biology and disease and train clinicians and scientists to become future leaders of these fields.The Cardiovascular Research Institute provides a home for a wide spectrum of investigation ranging from the most basic science to disease-focused and patient-based research. It also links faculty interested in cardiovascular biology and disease across Mount Sinai programs, departments, and campuses. The diversity of the faculty and its collaborative culture fosters a multidisciplinary approach to research problems and provides an important bridge between Mount Sinai's outstanding clinical and basic science departments. The research programs in Molecular and Cellular Cardiology have received substantial funding from the NIH, AHA and ACC. There are myriad opportunities for cardiology fellows to pursue basic and translational research. Fellows participating in the program have been involved in major research efforts in the areas of atherosclerosis, heart failure, transplant biology, cardiac excitation, ion channels, cardiomyopathy, and thrombosis. Fellows take courses in Molecular Biology, Cell Biology, Signal Transduction, Physiology and Neurobiology offered through the Graduate School Faculty of Mount Sinai. Fellows participate in journal clubs and seminars offered by the Brookdale Molecular Biology Center and the Molecular Medicine Program. Typically, fellows have presented the results of their work at the most prestigious international meetings of the American Heart Association, American College of Cardiology and American Federation for Medical Research (formerly AFCR).
Cardiovascular Disease Epidemiology Training Program – Johns Hopkins University School of Public Health
Josef Coresh, M.D.
George W. Comstock Professor
2024 E. Monument Street
Room 2-635, Suite 2-600
Baltimore, Maryland 21287
Shoshana Ballew, PhD
Assistant Program Director
Program Scope and Mission – Established in 1975, the Cardiovascular Disease Epidemiology Training Program focuses on interdisciplinary training on the epidemiology of the leading cause of death in the United States. The program integrates knowledge on all aspects of cardiovascular disease: biology, behavior, treatment and prevention. Training emphasizes active participation in research and translational epidemiology using a collaborative approach, which is enhanced by the close relationships between the Department of Epidemiology and the clinical departments of the Johns Hopkins School of Medicine at the Johns Hopkins Hospital. A number of large ongoing cohort studies and clinical trials provide a rich environment for the conduct of research. The main didactic course focuses on risk factors for cardiovascular disease and strategies for prevention. Seminar-style courses offer a more in-depth understanding of disease pathophysiology and clinical management.The strengths of the program include the existing depth of interest and expertise in cardiovascular disease epidemiology at the Johns Hopkins Medical Institutions, as well as the enthusiasm, commitment, and experience in training and mentorship of the Program Director (Dr. Josef Coresh), Program Co-director (Dr. Elizabeth Selvin) and program faculty. Many trainees are based in the Welch Center for Prevention, Epidemiology and Clinical Research and are mentored by individuals active in both population-based and clinical research. Among other outstanding collaborations, the program benefits from close ties with the Johns Hopkins University Divisions of General Internal Medicine, Cardiology and Endocrinology.
Pathophysiology of Myocardial Disease – The Johns Hopkins University School of Public Health
Dr. Wendy Post, MD
Professor of Medicine
Dr. David A. Kass, MD
Abraham and Virginia Weiss Professor of Cardiology
For Vascular Biology: Thorsten Leucker, MD, PhD
Program Scope and Mission – The Johns Hopkins Pathophysiology of Myocardial Disease T32 program trains post-doctoral fellows in multiple areas of heart and vascular disease, spanning basic science through to clinical translational, population, and bio-informatics/modeling disciplines. Dr. Wendy Post and Dr. David Kass are co-PIs of this program first established in 1974 and running continuously for over 45 years. For further information about the Division of Cardiology T-32 grant and eligibility criteria for interested applicants please see https://www.hopkinsmedicine.org/heart_vascular_institute/cardiovascular-research/johns-hopkins-cardiovascular-training-grant.html
Of particular interest to NAVBO are our opportunities to study vascular biology related themes with faculty from the Division of Cardiology, and other Divisions/Departments in the School of Medicine and Johns Hopkins University. These faculty provide expertise and training opportunities in all aspects of vascular biology with an emphasis on exploring molecular mechanisms of vascular inflammation and thrombosis and translating these findings to the clinical arena. Basic studies of vascular inflammation are applied to patients with conditions such as acute coronary syndrome, SARS-CoV-2 infection, metabolic syndrome, HIV infection, and aging. We are using imaging modalities including positron emission tomography (PET) and magnetic resonance imaging (MRI) to study endothelial cell function and assess vascular inflammation in patients.
In addition, our vascular biology program integrates novel high throughput sequencing technologies, such as single cell RNA-seq, single cell ATAC-seq, ChIP-seq and Hi-C techniques, together with state-of-the-art computational methods and targeted wet lab experiments to discover novel genetic mechanisms for atherosclerotic cardiovascular disease (ASCVD). Our work also focuses on genetic ASCVD mechanisms that affect components of the vascular wall, including endothelial cells, vascular smooth muscle cells, vascular fibroblasts and vascular macrophages. Trainees can learn and apply new genomic technologies and experimental genome editing methods to obtain insights on the physiology and pathophysiology of vascular function and disease.
Training Program in the Molecular Bases of Eye Diseases - Schepens Eye Research Institute, Boston, MA
Dr. Patricia D’Amore, PhD, MBA, FARVO
Department of Ophthalmology at Harvard Medical School
Program Scope and Mission – The Training Program in the Molecular Bases of Eye Diseases (MBED) is an ongoing postdoctoral training program in the Department of Ophthalmology at Harvard Medical School (HMS) that is aimed at attracting and mentoring talented and motivated basic scientist trainees in the field of vision research. The program includes 40 faculty members who represent a wide choice of research interests and expertise to the trainees in the program. The mentors represent a diversity of relevant disciplines including development, ocular immunology, vascular biology, neurobiology, regenerative medicine, gene therapy, growth factor biology, to name a few. In addition, the research faculty are investigating a number of important ocular pathologies such as age related macular degeneration, glaucoma, retinopathy of prematurity, retinal degenerations, corneal inflammation, wound healing, dry eye and corneal transplantation. This diversity provides a wide selection of training opportunities. The training program seeks to train scientists who will use a range of disciplines to investigate, the cause of blinding diseases with the goal of identifying methods for earlier diagnosis, more effective treatments, means for prevention and eventually to develop cures.
Since the initiation of the program in 1997, the program has trained and mentored 78 trainees, many of who continue in the field of vision research and whose achievements are reflected in their publications and presentation record. The goal of the MBED training program is to provide trainees with expertise in molecular approaches and models as well as an understanding of and the ability to recognize the important clinical and basic research questions facing ophthalmology. The commitment of the faculty to the success of their trainees is evidenced by the quality and success of resulting trainees. The location of the affiliate institutions in Boston provides an outstanding research environment with access to excellent facilities and resources. The program encompasses all aspects of training required to produce an independent and successful vision researcher including: full-time research, didactic courses and mentoring. These are all aimed at educating well qualified trainees in knowledge and understanding of the basic and clinical principles that are key to identifying and solving important ophthalmic problems, instruction in grant and manuscript writing and review as well as presentation skills, and training in the responsible conduct of research.
Cardiovascular Pathophysiology Training Program-Temple University, Philadelphia PA
Steven Houser, Ph.D., Professor of Physiology
Director, Independence Blue Cross Cardiovascular Research Center
Lewis Katz School of Medicine, Temple University
Independence Blue Cross Cardiovascular Research Center
3500 N. Broad Street, 10th Floor
Philadelphia, PA 19140
Program Scope and Mission – The Independence Blue Cross Cardiovascular Research Center (CVRC) is a consortium of basic and clinical scientists with a broad mission to develop new knowledge that will lead to better understanding of the causes of cardiovascular diseases. The CVRC facilitates multilevel, interdisciplinary collaborations that help target basic research towards clinical challenges and enables translation of discoveries into novel approaches for the detection, treatment and prevention of debilitating cardiovascular disorders.• Cellular and molecular bases of human heart failure
• Pathophysiology of cardiac functional remodeling after myocardial infarction
• Biology of proliferative arteriopathy (restenosis and allograft arteriopathy)
• Transplant immunology and allograft vasculopathy
• Hypertension: Fundamental mechanisms and strategies for reversal
• Stem cells and cardiac repair
• Cardiac hypertrophy
• Immunology and cardiac disease
• Microvascular function in health and disease
• Congestive heart failure
• Metabolic syndrome, diabetes and cardiovascular disease CVRC investigators employ a wide spectrum of in vitro techniques, relevant animal models and patient-based research methods. Research is conducted within a new medical research building at the Lewis Katz School of Medicine. CVRC core laboratories supply investigators with small and large animal models of cardiovascular disease for their studies. Open laboratory space enhances collaboration and the student/fellow experience. The CVRC training program has been and continues to be funded by a T32 training grant awarded by the National Heart, Lung and Blood institute. This funding provides a broad-based, multidisciplinary training experience for pre-doctoral, post-doctoral fellows, and summer medical students in integrative cardiovascular pathophysiology.
Transdisciplinary Training in Cardiovascular Research – University of Massachusetts Medical School
Catarina I. Kiefe, Ph.D., M.D.
Chair and Professor
University of Massachusetts Medical School
Program Scope and Mission – The University of Massachusetts Medical School (UMMS) has a cardiovascular T32 training grant entitled "Transdisciplinary Training in Cardiovascular Research" under the direction and senior leadership of Drs. Catarina Kiefe and John Keaney. The program represents a wonderful opportunity for the institution to promote the entire spectrum (T0 – T2+) of cardiovascular research on the UMMS campus. A call has been issued to request applications from trainees who wish to become part of this exciting program at the post-doctoral level. New trainees will join four other current trainees in the program.Eligibility: Please see http://grants.nih.gov/grants/guide/pa-files/PA-14-015.html Applicants must show evidence of high academic performance in the sciences and commitment to a career as an independent researcher. Post-doctoral candidates must have received a PhD, MD, DO, DC, DDS, DVM, OD, DPM, ScD, DrPH, DNSc, PharmD, PsyD, or equivalent doctoral degree from an accredited domestic or foreign institution. By the time of the award, the individual must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status). This fellowship program may not be used to support the clinical years of residency training. However, these awards are appropriate for the research fellowship years of a residency program. Research clinicians must devote full-time to their proposed research training and confine clinical duties to those activities that are part of the research training program.
Cardiovascular Disease Epidemiology Training Program - University of Pittsburgh
Akira Sekikawa, MD, PhD
Emma Barinas-Mitchell, PhD
Program Scope and Mission – This NHLBI-funded T32 program addresses the critical need to promote epidemiological research of cardiovascular disease (CVD). The primary goal is to train individuals in CVD Epidemiology based on a pathophysiological understanding and experiential learning to develop better prevention strategies in future. Our program offers multiple opportunities to pursue training related to CVD in a variety of areas including vascular aging, high risk and international populations, women’s health, nutrition and environment, physical activity and psychosocial factors, grounded in traditional and novel epidemiological and analytical methods. We emphasize Big Data including electronic health record and omics, Mobile Health and Cross Cohort Collaboration. The program current funds four pre-doctoral and 2 post-doctoral trainees.
Predoctoral Training In Pharmacological Sciences - University of Pittsburgh, School of Medicine
Patrick J. Pagano, Ph.D., FAHA
Professor & Vice-Chair for Graduate Education
Department of Pharmacology & Chemical Biology
Molecular Pharmacology Program
Vascular Medicine Institute
Ms. Shannon Granahan
Coordinator, Molecular Pharmacology Program
BST Starzl Tower: W1340
University of Pittsburgh School of Medicine
Pittsburgh, PA 15261
Program Scope and Mission – Molecular Pharmacology is a basic science into the molecular exploration of fundamental cellular processes in normal physiology and in disease. The Molecular Pharmacology Training Program (MPTP) of the University of Pittsburgh is a comprehensive, interdisciplinary program that provides research training in the basic and translational aspects of Pharmacology. The MPTP offers formal training through coursework and provides research opportunities individually tailored to suit each student. The program is outstanding in its long-term innovations in training students to be critical thinkers and leaders in their career track of choice as well as to complete their dissertation in a timely manner. The Pharmacology Training Program T32 provides up to 2-years of support in a wide range of disciplines ranging from cardiovascular disease to cancer therapy, neuropharmacology and GPCR receptor signaling.
Cardiovascular Behavioral Medicine Research Training – University of Pittsburgh
Dr. Karen Matthews, Ph.D.
Distinguished Professor of Psychiatry, School of Medicine
Karen A. Matthews, Ph.D.
Department of Psychiatry
University of Pittsburgh
3811 O’Hara Street
Pittsburgh, PA 15213
Program Scope and Mission – Cardiovascular behavioral medicine is defined as the application of psychological and behavioral principles and theory to understanding the etiology, course, prevention and treatment of, and recovery from, cardiovascular diseases (CVD). As such, it is a multidisciplinary field that requires high quality and broad training in behavior and behavior change, research methods and statistics, and cardiovascular physiology, pathophysiology, and CVD outcomes. Beginning in 1983, our program offers training in cardiovascular behavioral medicine research at three levels: postdoctoral, predoctoral, and short-term medical student research training. Our program supports 4 predoctoral and 4 postdoctoral fellowships and 2 medical student summer research traineeships per year.Our program for the post- and pre-doctoral fellows is designed to foster proficiency in four areas that comprise the foundations of cardiovascular behavioral medicine: 1. Principles of health behavior and health behavioral change, through which an understanding is developed of theoretical underpinnings of relevant areas of psychology, such as motivation, personality, emotion regulation, attitude and behavior change in individuals, with the latter focusing on physical activity, diet, smoking, and sleep behavior. 2. Research methodology and statistics, whereby the skills necessary for designing and conducting research and for drawing valid inferences from empirical data are taught, with exposure to analytic approaches to complex longitudinal data. 3. Cardiovascular physiology and psychophysiology, through which an understanding is established of cardiovascular and metabolic functioning in the healthy human and the new technological advances that allow measurement of function. 4. Cardiovascular diseases, including distributions of CVD in human populations, disparities between populations (e.g., by race/ethnicity, socioeconomic position, gender, etc.), principles of pathophysiology and physiology as related to disorders of the heart and vasculature, and state-of-the art approaches to assessing biomarkers of risk and imaging subclinical and clinical cardiovascular diseases. Building upon these foundations, our program facilitates the development of independent clinical research scientists who take a multidisciplinary approach within the following primary areas: (a) mechanistic pathways connecting psychosocial and sociodemographic factors to cardiovascular risk; (b) determinants and consequences of health behaviors; and (c) behavioral interventions to reduce cardiovascular risk.
Translational Research And Entrepreneurship In Pulmonary Vascular Biology - The University of Pittsburgh
Mark Gladwin, MD
Vascular Medicine Institute
University of Pittsburgh
Department of Medicine
Division of Cardiology, E1150 BST
200 Lothrop Street
Pittsburgh, PA 15261
Program Scope and Mission – Biomedical investigators are experiencing a limitation in their collective ability to translate the remarkable basic science discoveries of the current era into the clinical arena—a divide appropriately termed “the valley of death.” In our first cycle of funding, we developed a novel training program in bench-to-bedside research methodology designed to train the next generation of clinical and basic researchers in translational approaches to pulmonary vascular biology and medicine. In an effort to address the increasing pressure from the NIH, political leaders, and the public to translate basic discovery into therapeutic applications that positively change lives, we have recently extended the scope of our program to incorporate entrepreneurial training, including:
1) development of a novel joint University of Pittsburgh (ranked #5 in NIH funding)-Carnegie Mellon University MBA Program (ranked #1 in part-time programs) in Entrepreneurship;
2) elective rotations focused on commercialization of biotechnology; and
3) an expanded faculty that includes translational scientist-entrepreneurs.
Training Program in Imaging Sciences in Translational Cardiovascular Research - The University of Pittsburgh
Flordeliza Villanueva, MD.
Department of Medicine
Division of Cardiology, E1150 BST
200 Lothrop Street
Pittsburgh, PA 15261
Program Scope and Mission – Capabilities for biologic imaging at all levels--spanning molecules to man--have evolved to an unprecedented level of sophistication such that we can now visualize anatomic, functional, cellular, and molecular processes heretofore invisible, opening exciting new opportunities to study disease pathogenesis . In order for this ever- growing capacity to "see," to facilitate bedside translation of scientific discoveries, images must understand what questions are important in biomedical research, and conversely, biomedical scientists must be fluent in the imaging technologies that could revolutionize their work. However, there is a paucity of scientists who can comfortably commute between the spheres of imaging science and biomedical research, resulting in a "disconnect" that stymies what should otherwise be a powerful, bi-directionally facilitative, relationship between imaging science and translational research. To close this chasm, our new T32 Program employs an innovative educational paradigm to train future clinical and basic researchers in a broad spectrum of cutting edge, multimodality imaging platforms as they pursue hypothesis-driven research, with a specific emphasis on translational cardiovascular research. While there are T32s focused on traditional cardiovascular imaging tools (e.g., MRI, SPECT, Echo), to our knowledge, no training program comprehensively integrates biological imaging within translational biological and physical sciences. Our post-doctoral trainees (MD or PhD) will acquire "core competencies" in imaging methods spanning molecular to whole organism ("imaging tool kit") and in the conduct of translational research spanning basic to population levels ("translational tool kit') -- accomplished through a co-mentorship structure, with each trainee having one mentor from the imaging sciences, and another from the biomedical science arena. Our training strategy is structured around Individualized Development Plans that emphasize quantifiable outcomes based on abstract presentations, publications, pursuit of career development grants, completion of didactic courses, or completion of Masters Programs.
The Director, Dr. Villanueva, is a cardiologist, imaging specialist, and translational researcher with extensive mentoring experience. In actualizing the reciprocal relationship between imaging sciences and biomedical research espoused by this T32, she has been at the forefront of molecular probe and ultrasound technology development for molecular imaging and therapeutics. Our Training Committee comprises the Director and 3 co-Directors with expertise in basic, translational, and clinical research and training. Our 15 Imaging Faculty embody the full gamut of state-of-the-art imaging technologies, and 16 Biomedical Science Faculty offer multiple levels of translational research topics in cardiovascular medicine. The Program is enhanced by institutional endowments to Cardiology and the Heart, Lung, Blood, and Vascular Medicine Institute (VMI), a rich infrastructure from the Clinical Sciences Translational Institute and Center for Ultrasound Molecular Imaging and Therapeutics, VMI Cores, and interactions with other institutional translational T32s.
Training in Multi-Modality Molecular and Translational Cardiovascular Imaging - Yale University School of Medicine
Albert J. Sinusas, MD
Yale University School of Medicine
Section of Cardiovascular Medicine, DANA-3
P.O. Box 208017
New Haven, CT 06520-8017
James Duncan Ph.D.
300 Cedar Street
New Haven, CT 06520-8042
Program Scope and Mission – The training program is focused on providing multi-disciplinary multi-modality training in molecular and translational cardiovascular imaging for highly qualified fellows holding either a MD or/and PhD, in preparation for academic careers as independent investigators in the highly clinically relevant field of cardiovascular imaging. Post-doctoral fellowship training will be 2-3 years in duration. Currently four fellowship slots are available, although this will be expanded to six. There are three primary research focuses in the post-doctoral training, 1) cardiovascular molecular imaging, 2) cardiovascular imaging technologies and analyses, and 3) translational cardiovascular imaging. Applicants will have full access to resources available through the Yale Translational Research Imaging Center (Y-TRIC), including: small and large animal surgical suite, state-of-the-art digital fluoroscopy suite, 3D ultrasound, novel hybrid CZT SPECT 64-slice CT, microSPECT/CT, microCT, and optical imaging, along with other institutional resources, including; PET/CT, and MRI. Participation in ongoing NIH funded projects. Applications are encouraged from clinical, engineering, and basic science departments. Each trainee is assigned a basic and clinical mentor, and participates in group projects, and weekly seminar series. The goal is to train individuals to work in a multi-disciplinary research environment. Applicants are encouraged to visit our website: http://y-tric.yale.edu/.
Your program can be listed here - click for more information